These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin. Takahashi Y, Takesue Y, Takubo S, Ishihara M, Nakajima K, Tsuchida T, Ikeuchi H, Uchino M. J Infect Chemother; 2013 Aug; 19(4):709-16. PubMed ID: 23345049 [Abstract] [Full Text] [Related]
24. Fluorescence polarization immunoassay: can it result in an overestimation of vancomycin in patients not suffering from renal failure? Sym D, Smith C, Meenan G, Lehrer M. Ther Drug Monit; 2001 Aug; 23(4):441-4. PubMed ID: 11477330 [Abstract] [Full Text] [Related]
26. Restricted-access media high pressure liquid chromatography vs fluorescence polarization immunoassay for analysis of carbamazepine in human plasma. Ma J, Zhu PL, Xie JW, Jia ZP, Yang JS. Acta Pharmacol Sin; 2002 Jan; 23(1):87-91. PubMed ID: 11860744 [Abstract] [Full Text] [Related]
27. Development of an on-site therapeutic drug monitoring method using a portable spectrometer. Todoroki K, Fukudo N, Kudoh Y, Mizuno H, Min JZ, Tanaka S, Uchida S, Namiki N, Toyo'oka T. Anal Sci; 2024 May; 40(5):863-869. PubMed ID: 38358581 [Abstract] [Full Text] [Related]
33. Underestimation of rat serum vancomycin concentrations measured by an enzyme-multiplied immunoassay technique and the strategy for its avoidance. Konishi H, Iga I, Nagai K. Drug Test Anal; 2014 Apr; 6(4):350-6. PubMed ID: 23943307 [Abstract] [Full Text] [Related]
34. Falsely Elevated Vancomycin Concentrations in a Patient Not Receiving Vancomycin. Tsoi V, Bhayana V, Bombassaro AM, Tirona RG, Kittanakom S. Pharmacotherapy; 2019 Jul; 39(7):778-782. PubMed ID: 31077424 [Abstract] [Full Text] [Related]
35. Evaluation of an automated fluorescence polarization immunoassay for vancomycin. Filburn BH, Shull VH, Tempera YM, Dick JD. Antimicrob Agents Chemother; 1983 Aug; 24(2):216-20. PubMed ID: 6357070 [Abstract] [Full Text] [Related]
38. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. Iwamoto T, Kagawa Y, Kojima M. Biol Pharm Bull; 2003 Jun; 26(6):876-9. PubMed ID: 12808304 [Abstract] [Full Text] [Related]
39. Assay of vancomycin by fluorescence polarisation immunoassay and EMIT in patients with renal failure. Saunders NJ, Want SV, Adams DJ. J Antimicrob Chemother; 1995 Aug; 36(2):411-5. PubMed ID: 8522471 [Abstract] [Full Text] [Related]
40. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation. Khoschsorur G, Fruehwirth F, Zelzer S, Stettin M, Halwachs-Baumann G. Clin Chim Acta; 2007 May 01; 380(1-2):217-21. PubMed ID: 17320846 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]